The evidence supporting the use of LMWH for the control of arterial or cardioembolic events is less strong, although there is indirect evidence suggesting its usefulness in the management of chronic AF, subacute ischemic stroke, and also in cases of prosthetic valves, this is a more controversial issue.
Menos contundente es la evidencia que apoya las HBPM en el control de eventos arteriales o cardioembólicos, si bien hay evidencia indirecta que sugiere su utilidad en el manejo de FA crónica, ACV isquémico subagudo; también, aunque ello es más controvertido, en prótesis valvulares.